Articles for author: Russ Cohen

Russ Cohen

Financial Stocks Near Record Year: Could Trump Deregulation Fuel Bigger Gains In 2025?

U.S. financial stocks are enjoying a banner year in 2024, with the sector posting the strongest yearly return in nearly three decades, fueled by the spectacular resilience of the American economy and soaring investor optimism for deregulation following Donald Trump‘s November election victory. The iShares U.S. Financial ETF IYF has skyrocketed 34% year-to-date, representing the ...

Russ Cohen

Mizuho Upgrades Tesla (TSLA)

Fintel reports that on December 17, 2024, Mizuho upgraded their outlook for Tesla (NasdaqGS:TSLA) from Neutral to Outperform. Analyst Price Forecast Suggests 48.48% Downside As of December 2, 2024, the average one-year price target for Tesla is $238.56/share. The forecasts range from a low of $25.11 to a high of $431.55. The average price target ...

Russ Cohen

Implied IJK Analyst Target Price: $107

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares S&P Mid-Cap 400 Growth ETF (Symbol: IJK), ...

Russ Cohen

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Marqeta, Inc. (MQ) Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Marqeta, Inc. (“Marqeta” or the “Company”) MQ securities between May 7, 2024 and November 4, 2024, inclusive (the “Class Period”). Marqeta investors have until ...

Russ Cohen

General Mills Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

General Mills, Inc. GIS will release earnings results for its second quarter, before the opening bell on Wednesday, Dec. 18. Analysts expect the Minneapolis, Minnesota-based company to report quarterly earnings at $1.22 cents per share, down from $1.25 per share in the year-ago period. General Mills projects to report revenue of $5.14 billion for the ...

Russ Cohen

Is It Worth Investing in Abercrombie (ANF) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock’s price, but are they really important? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let’s see ...

Russ Cohen

My 5 Tips to Set Your Portfolio Up for the Long Haul

In the spirit of Thanksgiving, I’d like to share some of my most important investing tips… Thanksgiving is just two days away, and I don’t know about you, but I’m looking forward to spending the extra time with family and friends, eating turkey and watching a little football. In the spirit of Thanksgiving, I’d like ...

Russ Cohen

AI Investment Boom to Aid Micron Technology's Q1 Earnings?

Micron Technology, Inc. MU is scheduled to report first-quarter fiscal 2025 results after market close on Dec. 18 and all signs point to another solid performance. The company is riding the wave of rising artificial intelligence (AI) investments and an improving memory chip market, positioning it as a key player in the tech sector’s ongoing ...

Russ Cohen

Could C3.ai Stock Help You Retire a Millionaire?

C3.ai (NYSE: AI) was one of the market’s hottest tech IPOs when it went public four years ago. The enterprise artificial intelligence (AI) software provider went public at $42 a share, and its stock more than quadrupled to a record high of $177.47 in less than a month. Yet by the end of 2022, C3.ai’s ...

Russ Cohen

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) APLT investors concerning the Company’s possible violations of federal securities laws. On November 27, 2024, Applied Therapeutics disclosed that it had received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) ...